Please enable JavaScript to continue using this application.

Compare $CRVO vs $SER | Chartloom

Compare

$CRVO vs $SER

CervoMed Inc · Serina Therapeutics Inc

CRVO

CervoMed Inc

SER

Serina Therapeutics Inc

Compare $CRVO vs $SER

Comparing CervoMed Inc and Serina Therapeutics Inc

CRVOCervoMed Inc

SERSerina Therapeutics Inc

CRVOCervoMed Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-95.7%

YTD performance

-58.7%

52W performance

-63.8%

FCF yield

-64.2%

SERSerina Therapeutics Inc

Market cap

$30M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-64.5%

FCF yield

-70.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRVO

SER

Detailed metrics comparison

CRVO

CervoMed Inc

SER

Serina Therapeutics Inc

Market Cap

CRVO$44M

SER$30M

Enterprise Value

CRVO$21M

SER$10M

Price

CRVO$3.22

SER$2.00

P/E Ratio

CRVON/A

SERN/A

P/S Ratio

CRVO131.50x

SER345.73x

EV/Sales

CRVO63.70x

SER207.28x

EV/EBITDA

CRVO0.00x

SER0.00x

P/B Ratio

CRVO1.99x

SER2.66x

P/FCF Ratio

CRVON/A

SERN/A

EV/FCF

CRVO-0.75x

SER-0.47x

PEG Ratio

CRVON/A

SERN/A

Forward P/E (NTM)

CRVON/A

SERN/A

Forward P/S (NTM)

CRVON/A

SERN/A

Revenue (TTM)

CRVO$331K

SER$0

Revenue Growth (YoY)

CRVO-95.7%

SERN/A

Forward Rev Growth

CRVO2153.6%

SER0.0%

Gross Margin (TTM)

CRVO0.0%

SER65.1%

Operating Margin (TTM)

CRVO0.0%

SER0.0%

EBITDA Margin (TTM)

CRVO-9406.8%

SER0.0%

Net Margin (TTM)

CRVO-9160.8%

SER0.0%

FCF Margin (TTM)

CRVO-8444.8%

SERN/A

Net Income (TTM)

CRVO$-30M

SER$-17M

FCF (TTM)

CRVO$-28M

SER$-21M

EPS (TTM)

CRVO-$2.96

SER-$1.03

ROE (TTM)

CRVO-15602.0%

SER-10679.0%

ROA (TTM)

CRVO-12834.0%

SER-9480.0%

ROIC (TTM)

CRVO-15602.0%

SER-8268.0%

Cash

CRVO$22M

SER$23M

Debt

CRVO$0

SER$3M

Net Cash/Debt

CRVO$22M

SER$20M

Current Ratio (TTM)

CRVO8.57x

SER6.65x

Quick Ratio (TTM)

CRVO8.36x

SER6.12x

Debt/Equity (TTM)

CRVO0.00x

SER0.16x

Debt/Assets (TTM)

CRVO0.0%

SER0.0%

Interest Coverage (TTM)

CRVON/A

SERN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

SER0.00x

Beta

CRVO-0.69

SER8.13

52W Performance

CRVO-63.8%

SER-64.5%

YTD Performance

CRVO-58.7%

SER-3.8%

% from 52W High

CRVO-67.8%

SER-65.0%

% from 52W Low

CRVO51.2%

SER63.9%

Asset Turnover (TTM)

CRVO0.07x

SER0.02x

FCF Yield (TTM)

CRVO-64.2%

SER-70.7%

Earnings Yield (TTM)

CRVO-69.7%

SER-56.2%

Dividend Yield (TTM)

CRVON/A

SERN/A

Rule of 40

CRVO-8,540.5

SER0.0

EV/GP/RG

CRVON/A

SERN/A

Ticker research

View CRVO research View SER research

Metric	CRVO CervoMed Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$44M	$30M
Enterprise Value	$21M	$10M
Price	$3.22	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	345.73x
EV/Sales	63.70x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$0
Revenue Growth (YoY)	-95.7%	N/A
Forward Rev Growth	2153.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9406.8%	0.0%
Net Margin (TTM)	-9160.8%	0.0%
FCF Margin (TTM)	-8444.8%	N/A
Net Income (TTM)	$-30M	$-17M
FCF (TTM)	$-28M	$-21M
EPS (TTM)	-$2.96	-$1.03
ROE (TTM)	-15602.0%	-10679.0%
ROA (TTM)	-12834.0%	-9480.0%
ROIC (TTM)	-15602.0%	-8268.0%
Financial Health
Cash	$22M	$23M
Debt	$0	$3M
Net Cash/Debt	$22M	$20M
Current Ratio (TTM)	8.57x	6.65x
Quick Ratio (TTM)	8.36x	6.12x
Debt/Equity (TTM)	0.00x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	8.13
52W Performance	-63.8%	-64.5%
YTD Performance	-58.7%	-3.8%
% from 52W High	-67.8%	-65.0%
% from 52W Low	51.2%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.02x
FCF Yield (TTM)	-64.2%	-70.7%
Earnings Yield (TTM)	-69.7%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View SER research

Valuation

P/S Ratio

CRVO

131.50x

SER

345.73x

EV/FCF

CRVO

-0.75x

SER

-0.47x

Growth & revenue

Revenue Growth TTM

CRVO

-95.7%

Forward Revenue Growth

CRVO

2153.6%

SER

0.0%

Profitability & performance

Gross Margin

SER

65.1%

CRVO

0.0%

ROE

SER

-10679.0%

CRVO

-15602.0%

FCF Yield %

CRVO

-64.2%

SER

-70.7%

52-Week Performance

CRVO

-63.8%

SER

-64.5%

Detailed metrics comparison

CRVO

CervoMed Inc

SER

Serina Therapeutics Inc

Market Cap

CRVO$44M

SER$30M

Enterprise Value

CRVO$21M

SER$10M

Price

CRVO$3.22

SER$2.00

P/E Ratio

CRVON/A

SERN/A

P/S Ratio

CRVO131.50x

SER345.73x

EV/Sales

CRVO63.70x

SER207.28x

EV/EBITDA

CRVO0.00x

SER0.00x

P/B Ratio

CRVO1.99x

SER2.66x

P/FCF Ratio

CRVON/A

SERN/A

EV/FCF

CRVO-0.75x

SER-0.47x

PEG Ratio

CRVON/A

SERN/A

Forward P/E (NTM)

CRVON/A

SERN/A

Forward P/S (NTM)

CRVON/A

SERN/A

Revenue (TTM)

CRVO$331K

SER$0

Revenue Growth (YoY)

CRVO-95.7%

SERN/A

Forward Rev Growth

CRVO2153.6%

SER0.0%

Gross Margin (TTM)

CRVO0.0%

SER65.1%

Operating Margin (TTM)

CRVO0.0%

SER0.0%

EBITDA Margin (TTM)

CRVO-9406.8%

SER0.0%

Net Margin (TTM)

CRVO-9160.8%

SER0.0%

FCF Margin (TTM)

CRVO-8444.8%

SERN/A

Net Income (TTM)

CRVO$-30M

SER$-17M

FCF (TTM)

CRVO$-28M

SER$-21M

EPS (TTM)

CRVO-$2.96

SER-$1.03

ROE (TTM)

CRVO-15602.0%

SER-10679.0%

ROA (TTM)

CRVO-12834.0%

SER-9480.0%

ROIC (TTM)

CRVO-15602.0%

SER-8268.0%

Cash

CRVO$22M

SER$23M

Debt

CRVO$0

SER$3M

Net Cash/Debt

CRVO$22M

SER$20M

Current Ratio (TTM)

CRVO8.57x

SER6.65x

Quick Ratio (TTM)

CRVO8.36x

SER6.12x

Debt/Equity (TTM)

CRVO0.00x

SER0.16x

Debt/Assets (TTM)

CRVO0.0%

SER0.0%

Interest Coverage (TTM)

CRVON/A

SERN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

SER0.00x

Beta

CRVO-0.69

SER8.13

52W Performance

CRVO-63.8%

SER-64.5%

YTD Performance

CRVO-58.7%

SER-3.8%

% from 52W High

CRVO-67.8%

SER-65.0%

% from 52W Low

CRVO51.2%

SER63.9%

Asset Turnover (TTM)

CRVO0.07x

SER0.02x

FCF Yield (TTM)

CRVO-64.2%

SER-70.7%

Earnings Yield (TTM)

CRVO-69.7%

SER-56.2%

Dividend Yield (TTM)

CRVON/A

SERN/A

Rule of 40

CRVO-8,540.5

SER0.0

EV/GP/RG

CRVON/A

SERN/A

Ticker research

View CRVO research View SER research

Metric	CRVO CervoMed Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$44M	$30M
Enterprise Value	$21M	$10M
Price	$3.22	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	345.73x
EV/Sales	63.70x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$0
Revenue Growth (YoY)	-95.7%	N/A
Forward Rev Growth	2153.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9406.8%	0.0%
Net Margin (TTM)	-9160.8%	0.0%
FCF Margin (TTM)	-8444.8%	N/A
Net Income (TTM)	$-30M	$-17M
FCF (TTM)	$-28M	$-21M
EPS (TTM)	-$2.96	-$1.03
ROE (TTM)	-15602.0%	-10679.0%
ROA (TTM)	-12834.0%	-9480.0%
ROIC (TTM)	-15602.0%	-8268.0%
Financial Health
Cash	$22M	$23M
Debt	$0	$3M
Net Cash/Debt	$22M	$20M
Current Ratio (TTM)	8.57x	6.65x
Quick Ratio (TTM)	8.36x	6.12x
Debt/Equity (TTM)	0.00x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	8.13
52W Performance	-63.8%	-64.5%
YTD Performance	-58.7%	-3.8%
% from 52W High	-67.8%	-65.0%
% from 52W Low	51.2%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.02x
FCF Yield (TTM)	-64.2%	-70.7%
Earnings Yield (TTM)	-69.7%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View SER research